Management of Patients with Hepatocellular Carcinoma and Extrahepatic Metastasis

Metastatic hepatocellular carcinoma: when, how, where and so what?

(2010) Teh-Ia Huo et al.   LIVER INTERNATIONAL

Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors

(2010) Miho Kanda et al.   LIVER INTERNATIONAL

Successful treatment of pulmonary metastases associated with advanced hepatocellular carcinoma by systemic 5-fluorouracil combined with interferon-α in a hemodialysis patient

(2009) Yoshio Katamura et al.   HEPATOLOGY RESEARCH

Complete pathological response of hepatocellular carcinoma with systemic combination chemotherapy

(2008) Daris Ferrari et al.   ANTI-CANCER DRUGS

Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population

(2008) Thomas Yau et al.   CANCER

Combined approach to hepatocellular carcinoma: a new treatment concept for nonresectable disease

(2008) Bruno M Strebel et al.   Expert Review of Anticancer Therapy

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

(2008) Ann-Lii Cheng et al.   LANCET ONCOLOGY

Sorafenib in Advanced Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   NEW ENGLAND JOURNAL OF MEDICINE